Empowered Funds Expands Major Stock Holdings Across Five Companies in Q2

Comfort Systems USA drew new stakes from several small institutional investors in Q2—Jones Financial Companies Lllp, Core Wealth Advisors LLC, Avalon Trust Co, and Kemnay Advisory Services Inc.—with Carolina Wealth Advisors LLC boosting its stake by about 63.6% to 18 shares; hedge funds and other institutional investors collectively own about 96.51% of the stock.
Regeneron Pharmaceuticals saw insider selling in August: Director Kathryn Guarini sold 400 shares (about $320,000 at $800) and Director Huda Y. Zoghbi sold 800 shares (about $640,000 at $800) under a pre-arranged Rule 10b5-1 trading plan.
Newmont Corporation’s CEO Natascha Viljoen sold 7,764 shares on Aug. 5 at $104 per share, for a total of about $807,456, as part of ongoing insider activity.
StoneX Group CFO William J. Dunaway sold 96,490 shares on Aug. 14 at $66.35, for a total of about $6,402,111.50, in a transaction disclosed in an SEC filing.
M&T Bank director Rudina Seseri sold 623 shares on Aug. 21 at $241.04 per share, for a total around $150,000, as part of pre-planned trading activity.
Empowered Funds LLC expanded its investment portfolio in the second quarter, building major positions across five companies worth a combined $190.47 million, according to Ticker Report and Watchlist News. The fund acquired 28,872 new shares of Comfort Systems USA valued at $57.2 million, increased its Regeneron stake by 18,345 shares to $21.18 million, and expanded Newmont to 578,679 shares worth $54.05 million.
The fund also purchased 289,293 shares of StoneX Group for $34.28 million and raised its M&T Bank position to 99,840 shares valued at $23.76 million. The moves signal confidence in industrials, pharmaceuticals, mining, financial services, and specialized trading sectors during a period of mixed market performance.
Empowered Funds' $57.2 million bet on Comfort Systems USA arrived as several small institutional investors entered the stock in Q2. Watchlist News reported that Jones Financial Companies, Core Wealth Advisors, Avalon Trust Co, and Kemnay Advisory Services all took new stakes. Carolina Wealth Advisors boosted its position by 63.6% to 18 shares.
Institutional investors now collectively own about 96.51% of Comfort Systems USA stock. This concentration suggests broad confidence in the HVAC and building systems company among money managers seeking exposure to commercial infrastructure and construction activity.
While Empowered Funds increased its Regeneron stake by $21.18 million, company insiders moved in the opposite direction during August. Ticker Report noted that Director Kathryn Guarini sold 400 shares for about $320,000 at $800 per share. Director Huda Y. Zoghbi sold 800 shares for roughly $640,000 at the same price under a pre-arranged Rule 10b5-1 trading plan.
The director sales total about $960,000 and suggest insiders may view current valuations as attractive exit points. Regeneron stock closed that week near $800, reflecting investor optimism about its immunology and oncology pipeline.
Insider selling accelerated at two other Empowered Funds holdings in mid-August. Newmont CEO Natascha Viljoen sold 7,764 shares on August 5 at $104 per share, totaling about $807,456. StoneX Group CFO William J. Dunaway executed a much larger sale on August 14, unloading 96,490 shares at $66.35 each for approximately $6.4 million.
The StoneX sale represents a major insider transaction at a time when Empowered Funds was building a $34.28 million position. M&T Bank director Rudina Seseri also sold 623 shares on August 21 at $241.04, netting about $150,000. These parallel insider exits and fund buying suggest divergent market views on near-term stock performance.
Empowered Funds' $190.47 million deployment reveals a preference for value and cyclical sectors heading into autumn. The positions in M&T Bank ($23.76 million) and Newmont ($54.05 million) reflect bets on financial services and precious metals. StoneX Group ($34.28 million) and Comfort Systems USA ($57.2 million) add exposure to trading platforms and infrastructure.
The fund's Regeneron holding ($21.18 million) provides pharma diversification amid a mix tilted toward industrials and commodities. This balance suggests the fund is positioning for economic resilience while maintaining exposure to secular growth in healthcare. Insider selling across multiple holdings may create near-term headwinds but rarely deters determined institutional accumulation.
Publishers
22
Articles
47
Reach
69